1,2,3,4,5,6-hexabromocyclohexane,
1,2,3,4,5,6-Hexabromocyclohexane,
1837-91-8,
Benzene hexabromide,
Cyclohexane, 1,2,3,4,5,6-hexabromo-,
JAK2 Inhibitor II,
NSC 7908,
ACMC-1BQJT,
AC1L2M9F,
SCHEMBL459442,
trans-alpha-Benzene hexabromide,
AC1Q25E6,
CHEMBL444236,
DTXSID4052687,
CHEBI:93940,
NSC7908,
QFQZKISCBJKVHI-UHFFFAOYSA-N,
HMS3268H22,
HMS3677C10,
NSC-7908,
ZINC1586309,
ANW-23174,
MFCD00059127,
Cyclohexane,2,3,4,5,6-hexabromo-,
AKOS015836040,
1,2,3,4,5,6-Hexabromo-cyclohexane,
FCH1320627,
1,2,3,4,5,6-Hexabromocyclohexane #,
NCGC00092358-01,
CC-02681,
TC-111919,
TR-008484,
1,2,3,4,5,6-hexakis(bromanyl)cyclohexane,
A4510,
FT-0633875,
A812818,
C-23212,
J-011778,
1,2,3,4,5,6-Hexabromocyclohexane, >=98% (HPLC),
BRD-K06817181-001-01-5,
I14-61911,
Hexabromocyclohexane,
HEXABROMOBENZENE,
Triethylphenylamium,
Triethylphenylammonium,
C6H6Br6,
C6-H6-Br6,
C12H20N,
KST-1B2943,
CID74603,
AR-1B5045,
C12-H20-N,
H0368,
A15361,
C500162,
310-24-7,
87-82-1,